1. Home
  2. Clinical Topics
  3. FDA approves new osteoporosis treatment
Clinical TopicsDrugs and DevicesWeb ExclusivesWomen's Health

FDA approves new osteoporosis treatment

Share

On April 9, the FDA approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of fracture.

Read more at FDA.gov.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts